Business ❯ Healthcare Industry ❯ Pharmaceutical Companies

Drug Development

Clinical Trials Market Access Approval Processes Market Competition

FDA Drug Approvals Slowed in Q3 as Missed Deadlines and CRLs Rose

Analysts attribute the slowdown to cumulative operational strain at the agency.